Mucopolysaccharidosis Type VII

Mucopolysaccharidosis Type VII, often abbreviated as MPS VII, is a rare genetic disorder that affects the body’s ability to break down certain sugars called glycosaminoglycans (GAGs). In this article, we will explain MPS VII in simple, plain English, making it easy to understand for everyone.

MPS VII is a genetic disorder caused by the deficiency of an enzyme called beta-glucuronidase. This enzyme is responsible for breaking down GAGs in the body. Without enough beta-glucuronidase, GAGs build up and cause various health problems.

Causes of MPS VII:

MPS VII is caused by a genetic mutation. When a person inherits two mutated copies of the gene responsible for producing beta-glucuronidase, they develop MPS VII. These mutations can be passed down from parents to their children.

Symptoms of MPS VII:

  1. Facial Features: Individuals with MPS VII may have distinctive facial features, including a flattened nose bridge, wide nostrils, and an enlarged head.
  2. Skeletal Abnormalities: Bone and joint problems are common in MPS VII. This can lead to joint stiffness, limited mobility, and short stature.
  3. Organ Enlargement: The liver and spleen can become enlarged due to the accumulation of GAGs.
  4. Respiratory Issues: Difficulty breathing and recurrent respiratory infections are common in MPS VII.
  5. Heart Problems: Some individuals with MPS VII may have heart valve abnormalities.
  6. Vision and Hearing Loss: This disorder can cause vision problems and hearing loss over time.
  7. Developmental Delay: Children with MPS VII may experience delays in reaching developmental milestones.
  8. Cognitive Impairment: MPS VII can lead to cognitive impairment and learning difficulties.
  9. Hernias: Individuals with MPS VII may develop hernias.
  10. Thickened Skin: The skin may become thickened and coarse in individuals with MPS VII.

Diagnosis of MPS VII:

Diagnosing MPS VII involves a combination of clinical evaluation and laboratory tests. Some common diagnostic tests include:

  1. Enzyme Assay: A blood or urine test can measure the levels of beta-glucuronidase enzyme activity.
  2. Genetic Testing: Genetic testing can identify the specific gene mutations responsible for MPS VII.
  3. Imaging: X-rays and MRI scans may reveal skeletal abnormalities and organ enlargement.
  4. Clinical Evaluation: A medical history and physical examination by a healthcare provider experienced in MPS VII can help confirm the diagnosis.

Treatment for MPS VII:

While there is no cure for MPS VII, various treatments and therapies can help manage the symptoms and improve the quality of life. Here are some treatment options:

  1. Enzyme Replacement Therapy (ERT): ERT involves regular infusions of a synthetic beta-glucuronidase enzyme to replace the missing or defective enzyme in the body. This can help reduce the buildup of GAGs.
  2. Physical Therapy: Physical therapy can help individuals with MPS VII maintain joint mobility and muscle strength.
  3. Occupational Therapy: Occupational therapy assists in improving daily living skills and independence.
  4. Speech Therapy: Speech therapy can be beneficial for those with speech and communication difficulties.
  5. Surgery: In some cases, surgery may be necessary to address skeletal abnormalities or organ enlargement.
  6. Medications: Medications may be prescribed to manage specific symptoms such as pain and respiratory issues.
  7. Supportive Care: Regular monitoring by a medical team with expertise in MPS VII is crucial for managing the disorder effectively.

Drugs for MPS VII:

There are no specific drugs to treat MPS VII directly, but certain medications can help manage symptoms and complications:

  1. Pain Relievers: Over-the-counter or prescription pain relievers may be used to alleviate pain associated with joint problems.
  2. Respiratory Medications: Bronchodilators and antibiotics can help manage respiratory issues.
  3. Hearing Aids: Hearing aids may be recommended to address hearing loss.
  4. Gastrointestinal Medications: Medications may be prescribed to manage gastrointestinal symptoms.
  5. Cardiac Medications: If heart problems develop, medications may be necessary to manage them.

Conclusion:

Mucopolysaccharidosis Type VII (MPS VII) is a rare genetic disorder that affects various aspects of a person’s health due to the buildup of glycosaminoglycans (GAGs) in the body. While there is no cure, treatments like enzyme replacement therapy and supportive care can help manage the symptoms and improve the quality of life for individuals with MPS VII. Early diagnosis and a comprehensive treatment plan can make a significant difference in the lives of those affected by this condition. If you suspect MPS VII or have a family history, consult a healthcare provider for proper evaluation and guidance.

 

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. Thank you for giving your valuable time to read the article.

  1. https://medlineplus.gov/skinconditions.html
  2. https://www.aad.org/about/burden-of-skin-disease
  3. https://www.usa.gov/federal-agencies/national-institute-of-arthritis-musculoskeletal-and-skin-diseases
  4. https://www.cdc.gov/niosh/topics/skin/default.html
  5. https://www.skincancer.org/
  6. https://illnesshacker.com/
  7. https://endinglines.com/
  8. https://www.jaad.org/
  9. https://www.psoriasis.org/about-psoriasis/
  10. https://books.google.com/books?
  11. https://www.niams.nih.gov/health-topics/skin-diseases
  12. https://cms.centerwatch.com/directories/1067-fda-approved-drugs/topic/292-skin-infections-disorders
  13. https://www.fda.gov/files/drugs/published/Acute-Bacterial-Skin-and-Skin-Structure-Infections—Developing-Drugs-for-Treatment.pdf
  14. https://dermnetnz.org/topics
  15. https://www.aaaai.org/conditions-treatments/allergies/skin-allergy
  16. https://www.sciencedirect.com/topics/medicine-and-dentistry/occupational-skin-disease
  17. https://aafa.org/allergies/allergy-symptoms/skin-allergies/
  18. https://www.nibib.nih.gov/
  19. https://rxharun.com/rxharun/rxharun/article-types/skin-care-beauty/skin-diseases-types-symptoms-treatment/
  20. https://www.nei.nih.gov/
  21. https://en.wikipedia.org/wiki/List_of_skin_conditions
  22. https://en.wikipedia.org/?title=List_of_skin_diseases&redirect=no
  23. https://en.wikipedia.org/wiki/Skin_condition
  24. https://oxfordtreatment.com/
  25. https://www.nidcd.nih.gov/health/
  26. https://consumer.ftc.gov/articles/w
  27. https://www.nccih.nih.gov/health
  28. https://catalog.ninds.nih.gov/
  29. https://www.aarda.org/diseaselist/
  30. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  31. https://www.nibib.nih.gov/
  32. https://www.nia.nih.gov/health/topics
  33. https://www.nichd.nih.gov/
  34. https://www.nimh.nih.gov/health/topics
  35. https://www.nichd.nih.gov/
  36. https://www.niehs.nih.gov
  37. https://www.nimhd.nih.gov/
  38. https://www.nhlbi.nih.gov/health-topics
  39. https://obssr.od.nih.gov/
  40. https://www.nichd.nih.gov/health/topics
  41. https://rarediseases.info.nih.gov/diseases
  42. https://beta.rarediseases.info.nih.gov/diseases
  43. https://orwh.od.nih.gov/

References